Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Formulary-Tailored Pharmacoeconomic Models Being Used By Rx Sales Reps

Executive Summary

Drug company field reps are using custom-tailored models to demonstrate pharmacoeconomic data to formulary committee members, Innovus exec David Thompson said at the pharmacoeconomics conference organized by the Institute for International Research in Philadelphia March 26.
Advertisement

Related Content

Amgen/Praecis Ask For FDA Meeting After Plenaxis Deemed "Not Approvable"
Amgen/Praecis Ask For FDA Meeting After Plenaxis Deemed "Not Approvable"
FDA Quality Of Life, Pharmacoeconomic Guidance Development On Hold
FDA Quality Of Life, Pharmacoeconomic Guidance Development On Hold
Interchangeability Of COX-2s And NSAIDs Will Be First RxIntelligence Study
Advertisement
UsernamePublicRestriction

Register

PS037588

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel